EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

A Longitudinal Assessment of Endometriosis Patients Prescribed Cannabis‐Based Medicinal Products: A Case Series From the UK Medical Cannabis Registry

Sara Getter iD, Simon Erridge, John Warner-Levy, Evonne Clarke, Katy McLachlan, Ross Coomber, Shelley Barnes, Alia Darweish Medniuk, Rahul Guru, Wendy Holden, Mohammed Sajad, Robert Searle und 5 weitere

Australian and New Zealand Journal of Obstetrics and Gynaecology · 2026

DOI: 10.1111/ajo.70078 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Australian and New Zealand Journal of Obstetrics and Gynaecology, 2026. Verfasst von Sara Getter und 16 weiteren Autor:innen. Beteiligte Einrichtung: Medical Cannabis Research Group, Imperial College London, London, UK. Hauptthemen laut MEDLINE: Endometriosis, Medical Marijuana, Chronic Pain. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Although there is growing evidence supporting the use of cannabis‐based medicinal products (CBMPs) for the management of chronic pain, there is a paucity of data on their effect on endometriosis‐associated chronic pain.

Aims

This study aimed to perform an analysis of pain‐specific and general health‐related quality of life (HRQoL) outcomes for patients with endometriosis‐associated chronic pain treated with CBMPs. Materials and Methods Primary outcomes included changes in patient‐reported outcome measures (PrOMs) from baseline to 1, 3, 6, 12 and 18 months. A repeated measures ANOVA was applied to assess changes in PrOMs at 1 to 18 months from baseline. Secondary outcomes included incidence and frequency of adverse events (AEs).

Results

Sixty‐three patients met inclusion criteria. Initiation of CBMPs was associated with improvements in all pain‐specific PrOMs from baseline to 18 months ( p < 0.050). EQ‐5D‐5L index value showed improvements between baseline and all months ( p < 0.050). Anxiety and sleep quality PrOMs showed improvements from baseline to 18 months ( p < 0.050). Minimal clinically significant differences (11%–37%), moderately important improvements (5%–22%) and substantial improvements (0%–11%) were observed in the Brief Pain Inventory (BPI) and pain severity visual analogue scale. Sixty‐two adverse events were reported by 16 (25.40%) participants.

Conclusions

This study observed an association between CBMP treatment and improvements in pain and HRQoL in patients with endometriosis. Causality cannot be inferred due to the nature of this observational study; however, these findings provide complementary evidence for the development of randomised controlled trials to assess the efficacy of CBMPs for endometriosis‐associated chronic pain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndometriosisMedical MarijuanaChronic PainHumansFemaleAdultQuality of LifeUnited KingdomRegistriesPatient Reported Outcome MeasuresLongitudinal StudiesMiddle AgedAnxiety

Stichwörter der Autor:innen

cannabidiolcannabisendometriosispaintetrahydrocannabinol

Substanzen

Medical Marijuana

Autor:innen und Institutionen

  • Medical Cannabis Research Group, Imperial College London, London, UK.
  • Curaleaf Clinic, London, UK.
  • St. George's Hospital NHS Trust, London, UK.
  • North Bristol NHS Trust, Bristol, UK.
  • Cardiff and Vale University Health Board, Cardiff, UK.
  • Department of Psychological Medicine, Kings College London, London, UK.

ORCID-Profile: Sara Getter

Zitieren

APA

Getter, S., Erridge, S., Warner-Levy, J., Clarke, E., McLachlan, K., Coomber, R., Barnes, S., Darweish Medniuk, A., Guru, R., Holden, W., Sajad, M., Searle, R., Usmani, A., Varma, S., Rucker, J. J., Platt, M., & Sodergren, M. H. (2026). A Longitudinal Assessment of Endometriosis Patients Prescribed Cannabis‐Based Medicinal Products: A Case Series From the UK Medical Cannabis Registry. Australian and New Zealand Journal of Obstetrics and Gynaecology. https://doi.org/10.1111/ajo.70078

Vancouver

Getter S, Erridge S, Warner-Levy J, Clarke E, McLachlan K, Coomber R, et al. A Longitudinal Assessment of Endometriosis Patients Prescribed Cannabis‐Based Medicinal Products: A Case Series From the UK Medical Cannabis Registry. Australian and New Zealand Journal of Obstetrics and Gynaecology. 2026. doi:10.1111/ajo.70078

BibTeX
@article{Getter2026,
  author = {Getter, Sara and Erridge, Simon and Warner-Levy, John and Clarke, Evonne and McLachlan, Katy and Coomber, Ross and Barnes, Shelley and Darweish Medniuk, Alia and Guru, Rahul and Holden, Wendy and Sajad, Mohammed and Searle, Robert and Usmani, Azfer and Varma, Sanjay and Rucker, James J and Platt, Michael and Sodergren, Mikael H},
  title = {A Longitudinal Assessment of Endometriosis Patients Prescribed Cannabis‐Based Medicinal Products: A Case Series From the UK Medical Cannabis Registry},
  journal = {Australian and New Zealand Journal of Obstetrics and Gynaecology},
  year = {2026},
  doi = {10.1111/ajo.70078}
}
Kostenlos starten →